A United States-based casino operator developing a gaming resort at Incheon, South Korea, has confirmed its interim chief executive will become officially its president and CEO.
U.S. tribal casino operator Mohegan Gaming and Entertainment said on Thursday that Ray Pineault would take on the roles with immediate effect.
Mr Pineault (pictured) had been the interim boss since March 31, when Mario Kontomerkos stepped down as president and chief executive.
Mohegan Gaming is developing the Inspire Entertainment Resort, a complex with a foreigner-only casino, near Incheon International Airport, South Korea’s main air hub.
The firm had confirmed in a March 31 announcement that the South Korean authorities had granted it a one-year postponement on the first-phase opening of Inspire.
Pharmaceuticals
Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington s disease and cognitive impairment; and addictive and compulsive disorders.
Read More